John Marioni (via Wellcome Sanger Institute)
April 28, 2022 08:30 AM EDTUpdated May 2, 04:31 PM
Bioregnum
Pharma

Aviv Regev re­cruits a ‘pur­ple uni­corn’ for the top post in the com­pu­ta­tion­al pil­lar she’s build­ing at Genen­tech

Two years af­ter Aviv Regev left her sci­en­tif­ic abode at the Broad and jour­neyed west to take over as the new head of re­search and …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times